Scientists reveal key mechanism behind age-related decline in brain vascular function
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Oct-2026 20:16 ET (29-Oct-2026 00:16 GMT/UTC)
A comprehensive 15-year study published in the Biodiversity Data Journal details the growing threat of extreme weather on White Storks (Ciconia ciconia) in Bulgaria. The research, which is part of the topical collection "Restoration of species of conservation importance," analyzes the admissions and treatment outcomes of injured storks at the Wildlife Rescue and Breeding Centre (WRBC) of the Green Balkans NGO between 2010 and 2025. The researchers found that juvenile storks are exceptionally vulnerable to extreme conditions. Also, survival rates for fire-related incidents were strikingly low at just 33% (32 out of 97 wildfire recorded cases of collapsed nests, etc.).
POSTECH-KRISO team develops an ultra-light underwater lens for broadband low-frequency sound focusing.
POSTECH Identifies True Cause of Prussian Blue Performance Loss — Surface Oxidation, Not Crystal Water, Is the Key Factor.
A research group has developed “TP-An,” a molecule that enables even low-energy, long-wavelength light to be used more effectively by solar cells and photocatalysts. The molecule can be used even at high concentrations that are difficult for traditional materials, suggesting their usefulness in technology.
A Korean research team has developed a new viral vector technology that significantly improves the production efficiency of next-generation cell and gene therapies known as CAR immune cell therapies, which are designed to recognize and destroy cancer cells. Dr. Chi Hoon Park and his research team at the Korea Research Institute of Chemical Technology (KRICT) discovered a novel envelope protein derived from Simian Retrovirus Type 2 (SRV2). The newly identified SRV2 envelope protein demonstrated superior performance compared with the widely used RD114 envelope protein derived from feline endogenous retrovirus, highlighting its potential for future large-scale manufacturing of CAR immune cell therapies.